{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:05:39Z","timestamp":1791309939401,"version":"4.3.1"},"reference-count":39,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Waldenstro\u0308m macroglobulinemia (WM) is a B-cell malignancy characterized by the ability of the B-cell clone to differentiate into plasma cells. Although the clinical syndrome and the pathologic characteristics are well defined, little is known about its biology and controversy still exists regarding its cell of origin. In this gene-expression study, we compared the transcription profiles of WM with those of other malignant B cells including (chronic lymphocytic leukemia [CLL] and multiple myeloma [MM]) as well as normal cells (peripheral-blood B cells and bone marrow plasma cells). We found that WM has a homogenous gene expression regardless of 6q deletion status and clusters with CLL and normal B cells on unsupervised clustering with very similar expression profiles. Only a small gene set has expression profiles unique to WM compared to CLL and MM. The most significantly up-regulated gene is IL6 and the most significantly associated pathway for this set of genes is MAPK signaling. Thus, IL6 and its downstream signaling may be of biologic importance in WM. Further elucidation of the role of IL-6 in WM is warranted as this may offer a potential therapeutic avenue.<\/jats:p>","DOI":"10.1182\/blood-2006-02-005488","type":"journal-article","created":{"date-parts":[[2006,6,28]],"date-time":"2006-06-28T01:49:59Z","timestamp":1151459399000},"page":"2755-2763","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":147,"title":["Gene-expression profiling of Waldenstro\u0308m macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma"],"prefix":"10.1182","volume":"108","author":[{"given":"Wee J.","family":"Chng","sequence":"first","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelandt F.","family":"Schop","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Price-Troska","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kay","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane F.","family":"Jelinek","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Lacy","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee C.","family":"Tschumper","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Leif","family":"Bergsagel","sequence":"additional","affiliation":[{"name":"From the Department of Hematology-Oncology, Mayo Clinic Scottsdale, AZ; Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN; Dana Faber Cancer Institute, Boston, MA; Division of Internal Medicine, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN; Department of Immunology and Division of Hematology, Mayo Clinic College of Medicine, Mayo Graduate School, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713310498200_REF1","doi-asserted-by":"crossref","unstructured":"Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstro\u0308m's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstro\u0308m's macroglobulinemia. Semin Oncol. 2003;30: 110-115.","DOI":"10.1053\/sonc.2003.50082"},{"key":"2019111713310498200_REF2","doi-asserted-by":"crossref","unstructured":"Kriangkum J, Taylor BJ, Strachan E, et al. Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood. 2006; 107: 2920-2027.","DOI":"10.1182\/blood-2005-09-3613"},{"key":"2019111713310498200_REF3","doi-asserted-by":"crossref","unstructured":"Kriangkum J, Taylor BJ, Treon SP, Mant MJ, Belch AR, Pilarski LM. Clonotypic IgM V\/D\/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood. 2004;104: 2134-2142.","DOI":"10.1182\/blood-2003-11-4024"},{"key":"2019111713310498200_REF4","doi-asserted-by":"crossref","unstructured":"Ackroyd S, O'Connor SJ, Owen RG. Rarity of IgH translocations in Waldenstrom macroglobulinemia. Cancer Genet Cytogenet. 2005;163: 77-80.","DOI":"10.1016\/j.cancergencyto.2005.04.009"},{"key":"2019111713310498200_REF5","doi-asserted-by":"crossref","unstructured":"Schop RF, Kuehl WM, Van Wier SA, et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood. 2002;100: 2996-3001.","DOI":"10.1182\/blood.V100.8.2996"},{"key":"2019111713310498200_REF6","doi-asserted-by":"crossref","unstructured":"Mansoor A, Medeiros LJ, Weber DM, et al. Cytogenetic findings in lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001;116: 543-549.","DOI":"10.1309\/6U88-357U-UKJ5-YPT3"},{"key":"2019111713310498200_REF7","doi-asserted-by":"crossref","unstructured":"Abraham RS, Ballman KV, Dispenzieri A, et al. Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis. Blood. 2005;105: 794-803.","DOI":"10.1182\/blood-2004-04-1424"},{"key":"2019111713310498200_REF8","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2019111713310498200_REF9","doi-asserted-by":"crossref","unstructured":"Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99: 1745-1757.","DOI":"10.1182\/blood.V99.5.1745"},{"key":"2019111713310498200_REF10","doi-asserted-by":"crossref","unstructured":"Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett. 2005;158: 20-29.","DOI":"10.1016\/j.toxlet.2005.02.004"},{"key":"2019111713310498200_REF11","doi-asserted-by":"crossref","unstructured":"Nolz JC, Tschumper RC, Pittner BT, Darce JR, Kay NE, Jelinek DF. ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype. Leukemia. 2005;19: 1018-1024.","DOI":"10.1038\/sj.leu.2403726"},{"key":"2019111713310498200_REF12","doi-asserted-by":"crossref","unstructured":"Schweighoffer E, Vanes L, Mathiot A, Nakamura T, Tybulewicz VL. Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. Immunity. 2003;18: 523-533.","DOI":"10.1016\/S1074-7613(03)00082-7"},{"key":"2019111713310498200_REF13","doi-asserted-by":"crossref","unstructured":"Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol. 2004;17: 954-961.","DOI":"10.1038\/modpathol.3800145"},{"key":"2019111713310498200_REF14","doi-asserted-by":"crossref","unstructured":"Avet-Loiseau H, Garand R, Lode L, Harousseau JL, Bataille R. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101: 1570-1571.","DOI":"10.1182\/blood-2002-08-2436"},{"key":"2019111713310498200_REF15","unstructured":"Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol. 1998;152: 1655-1665."},{"key":"2019111713310498200_REF16","doi-asserted-by":"crossref","unstructured":"Rawstron AC, Owen RG, Davies FE, et al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol. 1997;97: 46-55.","DOI":"10.1046\/j.1365-2141.1997.72653.x"},{"key":"2019111713310498200_REF17","doi-asserted-by":"crossref","unstructured":"Mateo G, Castellanos M, Rasillo A, et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res. 2005; 11: 3661-3667.","DOI":"10.1158\/1078-0432.CCR-04-1489"},{"key":"2019111713310498200_REF18","doi-asserted-by":"crossref","unstructured":"Schwartz GK. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. J Clin Oncol. 2005;23: 4499-4508.","DOI":"10.1200\/JCO.2005.18.341"},{"key":"2019111713310498200_REF19","doi-asserted-by":"crossref","unstructured":"Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374: 1-20.","DOI":"10.1042\/bj20030407"},{"key":"2019111713310498200_REF20","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.","DOI":"10.1084\/jem.194.11.1639"},{"key":"2019111713310498200_REF21","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.","DOI":"10.1038\/35000501"},{"key":"2019111713310498200_REF22","unstructured":"Jelinek DF, Tschumper RC, Stolovitzky GA, et al. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res. 2003;1: 346-361."},{"key":"2019111713310498200_REF23","doi-asserted-by":"crossref","unstructured":"Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188: 1679-1689.","DOI":"10.1084\/jem.188.9.1679"},{"key":"2019111713310498200_REF24","doi-asserted-by":"crossref","unstructured":"Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med. 1999;77: 266-281.","DOI":"10.1007\/s001090050350"},{"key":"2019111713310498200_REF25","doi-asserted-by":"crossref","unstructured":"Schop RF, Fonseca R. Genetics and cytogenetics of Waldenstro\u0308m's macroglobulinemia. Semin Oncol. 2003;30: 142-145.","DOI":"10.1053\/sonc.2003.50075"},{"key":"2019111713310498200_REF26","doi-asserted-by":"crossref","unstructured":"Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5: 251-262.","DOI":"10.1038\/nrc1589"},{"key":"2019111713310498200_REF27","doi-asserted-by":"crossref","unstructured":"Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341: 1520-1529.","DOI":"10.1056\/NEJM199911113412007"},{"key":"2019111713310498200_REF28","doi-asserted-by":"crossref","unstructured":"Sahota SS, Forconi F, Ottensmeier CH, et al. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood. 2002;100: 1505-1507.","DOI":"10.1182\/blood.V100.4.1505.h81602001505_1505_1507"},{"key":"2019111713310498200_REF29","doi-asserted-by":"crossref","unstructured":"Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102: 1515-1525.","DOI":"10.1172\/JCI3009"},{"key":"2019111713310498200_REF30","doi-asserted-by":"crossref","unstructured":"Oscier DG, Thompsett A, Zhu D, Stevenson FK. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 1997;89: 4153-4160.","DOI":"10.1182\/blood.V89.11.4153"},{"key":"2019111713310498200_REF31","doi-asserted-by":"crossref","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102: 3759-3764.","DOI":"10.1182\/blood-2003-03-0801"},{"key":"2019111713310498200_REF32","doi-asserted-by":"crossref","unstructured":"DuVillard L, Guiguet M, Casasnovas RO, et al. Diagnostic value of serum IL-6 level in monoclonal gammopathies. Br J Haematol. 1995;89: 243-249.","DOI":"10.1111\/j.1365-2141.1995.tb03296.x"},{"key":"2019111713310498200_REF33","doi-asserted-by":"crossref","unstructured":"Hatzimichael EC, Christou L, Bai M, Kolios G, Kefala L, Bourantas KL. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenstro\u0308m's macroglobulinemia. Eur J Haematol. 2001; 66: 1-6.","DOI":"10.1034\/j.1600-0609.2001.00152.x"},{"key":"2019111713310498200_REF34","doi-asserted-by":"crossref","unstructured":"Levy Y, Fermand JP, Navarro S, et al. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammopathy. Proc Natl Acad Sci U S A. 1990;87: 3309-3313.","DOI":"10.1073\/pnas.87.9.3309"},{"key":"2019111713310498200_REF35","doi-asserted-by":"crossref","unstructured":"Hideshima T, Anderson KC. Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer. 2002;2: 927-937.","DOI":"10.1038\/nrc952"},{"key":"2019111713310498200_REF36","doi-asserted-by":"crossref","unstructured":"Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC. Advances in biology of multiple myeloma: clinical applications. Blood. 2004;104: 607-618.","DOI":"10.1182\/blood-2004-01-0037"},{"key":"2019111713310498200_REF37","unstructured":"Zhan F, Dhodapkar M, Fassas A, Barlogie B, Shaughnessy J Jr. Gene expression profiling of Waldenstro\u0308m's macroglobulinemia: biologic and therapeutic implications. The Third Internation Workshop on Waldenstro\u0308m's Macroglobulinemia Abstract Book [abstract]. 2004: 30."},{"key":"2019111713310498200_REF38","doi-asserted-by":"crossref","unstructured":"Gutierrez N, Ocio E, Maiso P, et al. Gene expression profiling of B-lymphocyte and plasma cell populations from Waldenstro\u0308m's macroglobulinemia. Comparison with expression patterns of the same cell-counterparts from other B-cell neoplasm [abstract]. Blood. 2005; 106. Abstract 503.","DOI":"10.1182\/blood.V106.11.503.503"},{"key":"2019111713310498200_REF39","doi-asserted-by":"crossref","unstructured":"Guipaud O, Deriano L, Salin H, et al. B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features. Lancet Oncol. 2003;4: 505-514.","DOI":"10.1016\/S1470-2045(03)01171-9"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/8\/2755\/1283144\/zh802006002755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/8\/2755\/1283144\/zh802006002755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:05:11Z","timestamp":1627513511000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/108\/8\/2755\/22576\/Geneexpression-profiling-of-Waldenstrom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-02-005488","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}